The novel MEK inhibitor atebimetinib in combination with modified gemcitabine/nab-paclitaxel led to a 12-month overall ...

US scientists discover a new gene therapy technique that is able to modify prostate cancer cells so that a patient's body attacks and kills them.

The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...

IronMind AdvisorsKenny has faced it all—from a high-powered cybersecurity career to hitting rock bottom with alcohol, and even battling stage 2B prostate cancer. On Studio 17, he ...

Cancer care is undergoing a quiet but profound transformation, driven by technology, better understanding of disease biology, and a growing emphasis on quality of life.

J&J successfully acquired Halda Therapeutics for $3.05bn integrating Halda’s RIPTAC platform into J&J’s oncology portfolio.

Detailed price information for Aptevo Therapeutics Inc (APVO-Q) from The Globe and Mail including charting and trades.

Preliminary unaudited fourth quarter and full year 2025 net product revenue of approximately $22M and $73M respectively; cash ...

The World Health Organization (WHO) today called on countries to make fertility care safer, fairer and more affordable for all in its first-ever global guideline for the prevention, diagnosis and ...

A few years ago, I had a patient who affectionately went by the name “Pops.” At 85 years young, he was full of life and juggling multiple health issues alongside prostate cancer, yet determined not to ...

The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...